Trial NCT04356495, EudraCT 2020-001435-27
Publication COVERAGE - Duvignaud A, Clin Microbiol Infect (2022) (published paper)
Primary outcome on the report: 1) occurrence of grade 3-4-5 adverse events; 2) combination of hospitalisation, need for COVID19-related oxygen therapy at home or death

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.